434
Participants
Start Date
March 31, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
ABT-126
Low Dose
ABT-126
High Dose
placebo
Placebo
Site Reference ID/Investigator# 67585, Johannesburg
Site Reference ID/Investigator# 67583, Rosebank
Site Reference ID/Investigator# 67584, George
Site Reference ID/Investigator# 67582, Cape Town
Site Reference ID/Investigator# 67586, Belville
Site Reference ID/Investigator# 66525, Staten Island
Site Reference ID/Investigator# 68731, Haidari, Athens
Site Reference ID/Investigator# 68768, Berlin
Site Reference ID/Investigator# 68733, Athens
Site Reference ID/Investigator# 69959, Schwerin
Site Reference ID/Investigator# 71573, Dijon
Site Reference ID/Investigator# 68705, Toulouse
Site Reference ID/Investigator# 66524, Orlando
Site Reference ID/Investigator# 66529, West Palm Beach
Site Reference ID/Investigator# 66522, Delray Beach
Site Reference ID/Investigator# 66531, Tampa
Site Reference ID/Investigator# 68767, Hüttenberg
Site Reference ID/Investigator# 68729, Thessaloniki
Site Reference ID/Investigator# 66526, Elk Grove Village
Site Reference ID/Investigator# 68706, Paris
Site Reference ID/Investigator# 68704, Paris
Site Reference ID/Investigator# 68764, Freiburg im Breisgau
Site Reference ID/Investigator# 68765, Munich
Site Reference ID/Investigator# 77833, Limoges
Site Reference ID/Investigator# 69602, Long Beach
Site Reference ID/Investigator# 66528, Fresno
Site Reference ID/Investigator# 66527, San Francisco
Site Reference ID/Investigator# 66530, Hamden
Site Reference ID/Investigator# 66523, Bennington
Site Reference ID/Investigator# 71793, Gatineau
Site Reference ID/Investigator# 71794, Montreal
Site Reference ID/Investigator# 71798, Peterborough
Site Reference ID/Investigator# 71795, Toronto
Site Reference ID/Investigator# 71796, Verdun
Site Reference ID/Investigator# 69960, Mittweida
Site Reference ID/Investigator# 68730, Athens
Site Reference ID/Investigator# 68732, Athens
Site Reference ID/Investigator# 68735, Thessaloniki
Site Reference ID/Investigator# 67787, Bath
Site Reference ID/Investigator# 67784, Glasgow
Site Reference ID/Investigator# 67786, London
Site Reference ID/Investigator# 67785, Manchester
Site Reference ID/Investigator# 67783, Warrington
AbbVie (prior sponsor, Abbott)
INDUSTRY